David Thurtle
YOU?
Author Swipe
View article: Composite risk stratification models optimise the value of imaging in prostate cancer staging
Composite risk stratification models optimise the value of imaging in prostate cancer staging Open
The detection of distant metastases in prostate cancer (PCa) staging impacts upon prognosis and management options. CT scans and isotope bone scintigraphy (BS) remain the most widely used primary staging investigations, although PSMA PET i…
View article: Radical Cystectomy in England from 2013 to 2019 on 12,644 patients: An analysis of national trends and comparison of surgical approaches using Hospital Episode Statistics data
Radical Cystectomy in England from 2013 to 2019 on 12,644 patients: An analysis of national trends and comparison of surgical approaches using Hospital Episode Statistics data Open
Introduction We evaluate the data of 12,644 Radical Cystectomies in England (Open, Robotic and Laparoscopic) with trends in the adaption of techniques and post‐operative complications. Methods This analysis utilised national Hospital Episo…
View article: Radical Cystectomy in England from 2013-2019: An analysis of national trends and comparison of surgical approaches using Hospital Episode Statistics data
Radical Cystectomy in England from 2013-2019: An analysis of national trends and comparison of surgical approaches using Hospital Episode Statistics data Open
Introduction We evaluate the data of 12,644 Radical Cystectomies in England (Open, Robotic and Laparoscopic) with trends in the adaption of techniques and post‐operative complications. Methods This analysis utilised national Hospital Episo…
View article: Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database
Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database Open
None.
View article: Clinical impact of the <i>Predict</i> Prostate risk communication tool in men newly diagnosed with non-metastatic prostate cancer: a multi-centre randomised controlled trial
Clinical impact of the <i>Predict</i> Prostate risk communication tool in men newly diagnosed with non-metastatic prostate cancer: a multi-centre randomised controlled trial Open
Introduction Predict Prostate is a freely-available online personalised risk communication tool for men newly diagnosed with non-metastatic prostate cancer. Its accuracy has been assessed in multiple validation studies but the clinical imp…
View article: Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic review
Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic review Open
Objectives Men diagnosed with non-metastatic prostate cancer require standardised and robust long-term prognostic information to help them decide on management. Most currently-used tools use short-term and surrogate outcomes. We explored t…
View article: Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow‐up in active surveillance for prostate cancer
Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow‐up in active surveillance for prostate cancer Open
Objectives To test whether using disease prognosis can inform a rational approach to active surveillance (AS) for early prostate cancer. Patients and methods We previously developed the Cambridge Prognostics Groups (CPG) classification, a …
View article: MP48-10 USING PROGNOSIS TO GUIDE INCLUSION CRITERIA, STRATIFY FOLLOW UP AND DEFINE STANDARDIZED END-POINTS IN ACTIVE SURVEILLANCE FOR PROSTATE CANCER
MP48-10 USING PROGNOSIS TO GUIDE INCLUSION CRITERIA, STRATIFY FOLLOW UP AND DEFINE STANDARDIZED END-POINTS IN ACTIVE SURVEILLANCE FOR PROSTATE CANCER Open
You have accessJournal of UrologyProstate Cancer: Localized: Active Surveillance I (MP48)1 Apr 2019MP48-10 USING PROGNOSIS TO GUIDE INCLUSION CRITERIA, STRATIFY FOLLOW UP AND DEFINE STANDARDIZED END-POINTS IN ACTIVE SURVEILLANCE FOR PROSTA…
View article: PD17-01 EXTERNAL VALIDATION OF THE PREDICT PROSTATE TOOL FOR PROGNOSTICATION IN NON-METASTATIC PROSTATE CANCER: A STUDY IN 69,206 MEN FROM PROSTATE CANCER DATA BASE SWEDEN
PD17-01 EXTERNAL VALIDATION OF THE PREDICT PROSTATE TOOL FOR PROGNOSTICATION IN NON-METASTATIC PROSTATE CANCER: A STUDY IN 69,206 MEN FROM PROSTATE CANCER DATA BASE SWEDEN Open
You have accessJournal of UrologyProstate Cancer: Staging II (PD17)1 Apr 2019PD17-01 EXTERNAL VALIDATION OF THE PREDICT PROSTATE TOOL FOR PROGNOSTICATION IN NON-METASTATIC PROSTATE CANCER: A STUDY IN 69,206 MEN FROM PROSTATE CANCER DATA BA…
View article: PD63-07 UNDERSTANDING OF PROGNOSIS IN NON-METASTATIC PROSTATE CANCER: A RANDOMISED COMPARATIVE STUDY OF CLINICIAN ESTIMATES AGAINST THE PREDICT PROSTATE TOOL
PD63-07 UNDERSTANDING OF PROGNOSIS IN NON-METASTATIC PROSTATE CANCER: A RANDOMISED COMPARATIVE STUDY OF CLINICIAN ESTIMATES AGAINST THE PREDICT PROSTATE TOOL Open
You have accessJournal of UrologyGeneral & Epidemiological Trends & Socioeconomics: Practice Patterns, Quality of Life and Shared Decision Making IV (PD63)1 Apr 2019PD63-07 UNDERSTANDING OF PROGNOSIS IN NON-METASTATIC PROSTATE CANCER: A RA…
View article: MP24-18 SYSTEMATIC REVIEW AND META-ANALYSIS OF SIGNIFICANT CANCER DETECTION BY MRI-TARGETED BIOPSY COMPARED TO SYSTEMATIC BIOPSY
MP24-18 SYSTEMATIC REVIEW AND META-ANALYSIS OF SIGNIFICANT CANCER DETECTION BY MRI-TARGETED BIOPSY COMPARED TO SYSTEMATIC BIOPSY Open
You have accessJournal of UrologyProstate Cancer: Detection & Screening III (MP24)1 Apr 2019MP24-18 SYSTEMATIC REVIEW AND META-ANALYSIS OF SIGNIFICANT CANCER DETECTION BY MRI-TARGETED BIOPSY COMPARED TO SYSTEMATIC BIOPSY Veeru Kasivisvanat…
View article: Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model
Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model Open
BACKGROUND: Prognostic stratification is the cornerstone of management in nonmetastatic prostate cancer (PCa). However, existing prognostic models are inadequate-often using treatment outcomes rather than survival, stratifying by broad het…
View article: MP21-07 PREDICT: PROSTATE – A NOVEL PROGNOSTIC MODEL THAT ESTIMATES INDIVIDUAL SURVIVAL IN NEWLY DIAGNOSED PRIMARY NON-METASTATIC PROSTATE CANCER
MP21-07 PREDICT: PROSTATE – A NOVEL PROGNOSTIC MODEL THAT ESTIMATES INDIVIDUAL SURVIVAL IN NEWLY DIAGNOSED PRIMARY NON-METASTATIC PROSTATE CANCER Open
You have accessJournal of UrologyProstate Cancer: Epidemiology & Natural History I1 Apr 2018MP21-07 PREDICT: PROSTATE – A NOVEL PROGNOSTIC MODEL THAT ESTIMATES INDIVIDUAL SURVIVAL IN NEWLY DIAGNOSED PRIMARY NON-METASTATIC PROSTATE CANCER D…
View article: Improving the safety and tolerability of local anaesthetic outpatient transperineal prostate biopsies: A pilot study of the CAMbridge PROstate Biopsy (CAMPROBE) method
Improving the safety and tolerability of local anaesthetic outpatient transperineal prostate biopsies: A pilot study of the CAMbridge PROstate Biopsy (CAMPROBE) method Open
Objectives: The aim of this study was to pilot the use of a bespoke device (CAMPROBE, the CAMbridge PROstate Biopsy) to enable routine outpatient free-hand local anaesthetic (LA) transperineal prostate biopsies. Materials and methods: The …
View article: Progression and treatment rates using an active surveillance protocol incorporating image‐guided baseline biopsies and multiparametric magnetic resonance imaging monitoring for men with favourable‐risk prostate cancer
Progression and treatment rates using an active surveillance protocol incorporating image‐guided baseline biopsies and multiparametric magnetic resonance imaging monitoring for men with favourable‐risk prostate cancer Open
Objective To assess early outcomes since the introduction of an active surveillance (AS) protocol incorporating multiparametric magnetic resonance imaging (mpMRI)‐guided baseline biopsies and image‐based surveillance. Patients and Methods …
View article: Evolution and oncological outcomes of a contemporary radical prostatectomy practice in a <scp>UK</scp> regional tertiary referral centre
Evolution and oncological outcomes of a contemporary radical prostatectomy practice in a <span>UK</span> regional tertiary referral centre Open
Objective To investigate the clinical and pathological trends, over a 10‐year period, in robot‐assisted laparoscopic prostatectomy ( RALP ) in a UK regional tertiary referral centre. Patients and Methods In all, 1 500 consecutive patients …